Literature DB >> 26077239

Epirubicin, Cisplatin, and Capecitabine Versus Fluorouracil, Leucovorin, and Irinotecan for Esophagogastric Cancer: The Original and the Rest.

Elizabeth C Smyth1, David Cunningham2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26077239     DOI： 10.1200/JCO.2014.59.7088

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  The bromodomain and extra-terminal domain inhibitor JQ1 synergistically sensitizes human colorectal cancer cells to topoisomerase I inhibitors through repression of Mre11-mediated DNA repair pathway.

Authors:  Linping Lei; Xuqin Xie; Long He; Keling Chen; Zhaoying Lv; Bin Zhou; Yuan Li; Wenjun Hu; Zongguang Zhou
Journal:  Invest New Drugs       Date:  2020-09-26       Impact factor: 3.850

2.  The efficacy and adverse reactions of DCF and FOLFOXs regimens for patients with advanced gastric cancer in China: a meta-analysis.

Authors:  Minxue Chen; Yong Fan; Zhiqiang Zhao; Yuanhua Nie; Fulin Ma; Xingang Wang; Qiuya Wei; Yuebin Wang; Boxiong Kang; Yongyong Liu; Hao Chen; Chen Wang
Journal:  Transl Cancer Res       Date:  2020-07       Impact factor: 1.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.